SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-020883
Filing Date
2024-05-21
Accepted
2024-05-21 16:13:45
Documents
13
Period of Report
2024-05-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40731
  Complete submission text file 0001493152-24-020883.txt   216135

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE pcsa-20240521.xsd EX-101.SCH 3060
3 XBRL LABEL FILE pcsa-20240521_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE pcsa-20240521_pre.xml EX-101.PRE 22389
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3702
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39531 | Film No.: 24969507
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)